• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列全科医疗中高血压患者的风险因素概况及治疗目标达成情况:以色列血压控制(IBPC)项目的基线结果

Risk factor profile and achievement of treatment goals among hypertensive patients in general practice in Israel: baseline results from the Israeli Blood Pressure Control (IBPC) program.

作者信息

Leibovitz Eyal, Gavish Dov, Dicker Dror, Viskoper Reuven J, Yosefi Chaim

机构信息

Department of Internal Medicine A, Wolfson Medical Center, Holon, Israel.

出版信息

Isr Med Assoc J. 2003 Oct;5(10):697-701.

PMID:14719462
Abstract

BACKGROUND

The Israeli Blood Pressure Control program was initiated to enhance the control of modifiable risk factors among high risk hypertensive patients followed by general practitioners in Israel.

OBJECTIVE

To report the baseline results of the state of the treatment regarding blood pressure management, lipid and glucose control as well as obesity and smoking cessation among the patients.

METHODS

Hypertensive patients were screened in 30 general practice clinics supervised by family medicine specialists seeing 1,000-5,000 patients each. Between 50 and 250 hypertensive patints were diagnosed at each participating clinic. Blood pressure levels, body mass index, lipid and glucose levels, as well as target organ damage and medications were recorded for all patients.

RESULTS

Of the 4,948 patients registered, 2,079 were males (42%). Mean age was 64.8 +/- 12. Blood pressure control was achieved in only 33.1% of total hypertensive patients. Low density lipoprotein control was achieved in 31.1% of all patients, and glucose control in only 28.5%% of diabetic patients (glucose < 126 mg/dl); 20.7% of the diabetics had glucose levels above 200 mg/dl. In this group of patients 38.9% were obese (BMI > 30 kg/m2). While there were more obese females than males (48.0% vs. 35.6%), no difference was found in blood pressure, lipid or glucose control between the genders.

CONCLUSION

Risk factor management of hypertensive patients attending general practice clinics in Israel is not optimal, especially among those with diabetes or in need of secondary prevention measures. A long-term intervention program for high risk patients in the community is needed to improve the current situation.

摘要

背景

以色列启动了血压控制项目,以加强以色列全科医生所诊治的高危高血压患者中可改变危险因素的控制。

目的

报告患者在血压管理、血脂和血糖控制以及肥胖与戒烟方面的治疗基线结果。

方法

在30家由家庭医学专家监督的全科诊所对高血压患者进行筛查,每家诊所诊治1000 - 5000名患者。每家参与诊所诊断出50至250名高血压患者。记录所有患者的血压水平、体重指数、血脂和血糖水平以及靶器官损害和用药情况。

结果

在登记的4948名患者中,2079名是男性(42%)。平均年龄为64.8±12岁。仅33.1%的高血压患者实现了血压控制。31.1%的患者实现了低密度脂蛋白控制,仅28.5%的糖尿病患者实现了血糖控制(血糖<126mg/dl);20.7%的糖尿病患者血糖水平高于200mg/dl。在这组患者中,38.9%为肥胖(体重指数>30kg/m²)。虽然肥胖女性多于男性(48.0%对35.6%),但两性在血压、血脂或血糖控制方面未发现差异。

结论

以色列全科诊所高血压患者的危险因素管理并不理想,尤其是在糖尿病患者或需要二级预防措施的患者中。需要针对社区高危患者开展长期干预项目以改善当前状况。

相似文献

1
Risk factor profile and achievement of treatment goals among hypertensive patients in general practice in Israel: baseline results from the Israeli Blood Pressure Control (IBPC) program.以色列全科医疗中高血压患者的风险因素概况及治疗目标达成情况:以色列血压控制(IBPC)项目的基线结果
Isr Med Assoc J. 2003 Oct;5(10):697-701.
2
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysis.
Blood Press. 2003;12(4):225-31. doi: 10.1080/08037050310015485.
3
[Hypertension management in general practice in Iceland].[冰岛全科医疗中的高血压管理]
Laeknabladid. 2006 May;92(5):375-80.
4
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
5
[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].[原发性高血压患者治疗后昼夜血压及影响因素分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4.
6
For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.对于大多数糖尿病患者来说,血压和血脂管理不符合建议。来自德国一项基于大量人群的队列研究结果。
Pharmacoepidemiol Drug Saf. 2008 May;17(5):485-94. doi: 10.1002/pds.1589.
7
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.缬沙坦联合氢氯噻嗪与氨氯地平单药治疗对伴有其他心血管危险因素的高血压患者的疗效及耐受性比较:VAST研究
Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.
8
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).2型糖尿病合并冠心病患者的危险因素控制:来自瑞典国家糖尿病登记处(NDR)的研究结果
Diabet Med. 2009 Jan;26(1):53-60. doi: 10.1111/j.1464-5491.2008.02633.x.
9
Genetics, obesity, and environmental risk factors associated with type 2 diabetes.与2型糖尿病相关的遗传学、肥胖及环境风险因素。
Croat Med J. 2005 Apr;46(2):302-7.
10
[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].[慢性肾脏病(CKD)患者的动脉高血压和血脂异常。抗血小板聚集。目标导向治疗]
Nefrologia. 2008;28 Suppl 3:39-48.